EUVIMEDEUVIMED entdecken
Crossref

Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study

Mariam Anjum iD, Inger Ariansen iD, Vidar Hjellvik, Randi Selmer, Lars J Kjerpeseth, Eva Skovlund, Marius Myrstad, Hanne Ellekjær, Ingrid E Christophersen, Arnljot Tveit iD, Trygve Berge iD

European Heart Journal · 2024

DOI: 10.1093/eurheartj/ehad659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal, 2024. Verfasst von Mariam Anjum und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway. Hauptthemen laut MEDLINE: Stroke, Atrial Fibrillation, Brain Ischemia, Ischemic Stroke. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Norwegian South-East Regional Health Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims The benefit of oral anticoagulant (OAC) therapy in atrial fibrillation (AF) and intermediate stroke risk is debated. In a nationwide Norwegian cohort with a non-sex CHA2DS2-VASc risk score of one, this study aimed to investigate (i) stroke and bleeding risk in AF patients with and without OAC treatment, and (ii) the risk of stroke in non-anticoagulated individuals with and without AF.

Methods

A total of 1 118 762 individuals including 34 460 AF patients were followed during 2011–18 until ischaemic stroke, intracranial haemorrhage, increased CHA2DS2-VASc score, or study end. One-year incidence rates (IRs) were calculated as events per 100 person-years (%/py). Cox regression models provided adjusted hazard ratios (aHRs [95% confidence intervals]).

Results

Among AF patients, the ischaemic stroke IR was 0.51%/py in OAC users and 1.05%/py in non-users (aHR 0.47 [0.37–0.59]). Intracranial haemorrhage IR was 0.28%/py in OAC users and 0.19%/py in non-users (aHR 1.23 [0.88–1.72]). Oral anticoagulant use was associated with an increased risk of major bleeding (aHR 1.37 [1.16–1.63]) but lower risk of the combined outcome of ischaemic stroke, major bleeding, and mortality (aHR 0.57 [0.51–0.63]). Non-anticoagulated individuals with AF had higher risk of ischaemic stroke compared to non-AF individuals with the same risk profile (aHR 2.47 [2.17–2.81]).

Conclusions

In AF patients at intermediate risk of stroke, OAC use was associated with overall favourable clinical outcomes. Non-anticoagulated AF patients had higher risk of ischaemic stroke compared to the general population without AF with the same risk profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeAtrial FibrillationBrain IschemiaIschemic StrokeHumansRisk AssessmentRisk FactorsHemorrhageAnticoagulantsIntracranial Hemorrhages

Stichwörter der Autor:innen

Atrial fibrillationBleedingOral anticoagulationPreventionStroke risk

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.
  • Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
  • Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
  • Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.
  • Stroke Unit, Department of Internal Medicine, St.Olavs Hospital, Norway.
  • Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Norway.

ORCID-Profile: Mariam Anjum, Inger Ariansen, Arnljot Tveit, Trygve Berge

Förderung

  • Norwegian South-East Regional Health Authority

Zitieren

APA

Anjum, M., Ariansen, I., Hjellvik, V., Selmer, R., Kjerpeseth, L. J., Skovlund, E., Myrstad, M., Ellekjær, H., Christophersen, I. E., Tveit, A., & Berge, T. (2024). Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study. European Heart Journal. https://doi.org/10.1093/eurheartj/ehad659

Vancouver

Anjum M, Ariansen I, Hjellvik V, Selmer R, Kjerpeseth LJ, Skovlund E, et al. Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study. European Heart Journal. 2024. doi:10.1093/eurheartj/ehad659

BibTeX
@article{Anjum2024,
  author = {Anjum, Mariam and Ariansen, Inger and Hjellvik, Vidar and Selmer, Randi and Kjerpeseth, Lars J and Skovlund, Eva and Myrstad, Marius and Ellekjær, Hanne and Christophersen, Ingrid E and Tveit, Arnljot and Berge, Trygve},
  title = {Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study},
  journal = {European Heart Journal},
  year = {2024},
  doi = {10.1093/eurheartj/ehad659}
}
Kostenlos starten →